Kezar Life Sciences (KZR) Payables (2021 - 2025)
Historic Payables for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $911000.0.
- Kezar Life Sciences' Payables fell 7367.81% to $911000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $911000.0, marking a year-over-year decrease of 7367.81%. This contributed to the annual value of $3.7 million for FY2024, which is 5575.08% down from last year.
- As of Q3 2025, Kezar Life Sciences' Payables stood at $911000.0, which was down 7367.81% from $1.2 million recorded in Q2 2025.
- Over the past 5 years, Kezar Life Sciences' Payables peaked at $8.3 million during Q4 2023, and registered a low of $911000.0 during Q3 2025.
- Its 5-year average for Payables is $2.8 million, with a median of $2.3 million in 2022.
- As far as peak fluctuations go, Kezar Life Sciences' Payables surged by 23283.58% in 2023, and later plummeted by 7367.81% in 2025.
- Over the past 5 years, Kezar Life Sciences' Payables (Quarter) stood at $2.0 million in 2021, then grew by 22.24% to $2.5 million in 2022, then surged by 232.84% to $8.3 million in 2023, then tumbled by 55.75% to $3.7 million in 2024, then crashed by 75.05% to $911000.0 in 2025.
- Its last three reported values are $911000.0 in Q3 2025, $1.2 million for Q2 2025, and $2.0 million during Q1 2025.